Immunity by formulation design: Induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method-Reference-Cited by-同舟云学术

Immunity by formulation design: Induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method

Published:2011-03 Issue:3 Volume:150 Page:307-317
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Nordly Pernille,Rose Fabrice,Christensen Dennis,Nielsen Hanne Mørck,Andersen Peter,Agger Else Marie,Foged Camilla

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference71 articles.

1. Defining the antigen-specific T-cell response to vaccination and poly(I:C)/TLR3 signaling: evidence of enhanced primary and memory CD8 T-cell responses and antitumor immunity;Salem;J. Immunother.,2005

2. Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes;Zaks;J. Immunol.,2006

3. Polyriboinosinic polyribocytidylic acid [poly(I:C)]/TLR3 signaling allows class I processing of exogenous protein and induction of HIV-specific CD8+ cytotoxic T lymphocytes;Fujimoto;Int. Immunol.,2004

4. Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-alpha/beta;Durand;Immunol. Cell Biol.,2004

5. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant;Longhi;J. Exp. Med.,2009

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selection of vaccine-candidate peptides from Mycobacterium avium subsp. paratuberculosis by in silico prediction, in vitro T-cell line proliferation, and in vivo immunogenicity;Frontiers in Immunology;2024-01-30

2. Method of manufacturing CAF®09 liposomes affects immune responses induced by adjuvanted subunit proteins;European Journal of Pharmaceutics and Biopharmaceutics;2023-08

3. A novel defined TLR3 agonist as an effective vaccine adjuvant;Frontiers in Immunology;2023-01-24

4. Intravenous liposomal vaccine enhances CTL generation, but not until antigen presentation;Journal of Controlled Release;2022-03

5. Cytosolic dsRNA improves neonatal innate immune responses to adjuvants in use in pediatric vaccines;Journal of Leukocyte Biology;2022-01-31